Literature DB >> 33983431

Increased sensitivity of a new commercial reverse transcriptase-quantitative PCR for the detection of Pneumocystis jirovecii in respiratory specimens.

Sarah Dellière1,2, Samia Hamane1, Nesrine Aissaoui1, Maud Gits-Muselli1,2, Stéphane Bretagne1,2,3, Alexandre Alanio1,2,3.   

Abstract

Optimal sensitivity to detect low Pneumocystis loads is of importance to take individual and collective measures to avoid evolution towards Pneumocystis pneumonia and outbreaks in immunocompromised patients. This study compares two qPCR procedures, a new automated RTqPCR using the GeneLEAD VIII extractor/thermocycler (GLVIII; ∼2.2 h workflow) and a previously validated in-house qPCR assays (IH; ∼5 h workflow) both targeting mtSSU and mtLSU for detecting P. jirovecii in 213 respiratory samples. GLVIII was found to be more sensitive than IH, detecting eight more specimens. Bland-Altman analysis between the two procedures showed a Cq bias of 1.17 ± 0.07 in favor of GLVIII. LAY
SUMMARY: The fungus Pneumocystis needs to be detected early in respiratory samples to prevent pneumonia in immunocompromised hosts. We evaluated a new commercial RTqPCR on 213 respiratory samples to detect Pneumocystis and found it more sensitive and faster than our routine sensitive in-house qPCR assay.
© The Author(s) 2021. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Entities:  

Keywords:  zzm321990 Pneumocystis jiroveciizzm321990 ; zzm321990 Pneumocystis pneumoniazzm321990 ; diagnosis; mitochondria; real-time PCR

Mesh:

Year:  2021        PMID: 33983431     DOI: 10.1093/mmy/myab029

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  1 in total

1.  Development and Evaluation of Rapid and Accurate CRISPR/Cas13-Based RNA Diagnostics for Pneumocystis jirovecii Pneumonia.

Authors:  Yangqing Zhan; Xiaoqing Gao; Shaoqiang Li; Yeqi Si; Yuanxiang Li; Xu Han; Wenjun Sun; Zhengtu Li; Feng Ye
Journal:  Front Cell Infect Microbiol       Date:  2022-06-15       Impact factor: 6.073

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.